IDEAYA Biosciences’ Post

The rapid evolution of cancer care creates many challenges for providers. From navigating new technology deployment, to #staffing shortages, and rising care costs - Varian's Advanced Oncology Solutions is your trusted partner.    Our subject matter experts bring a holistic approach to optimizing and standardizing your clinical operations and workflows so you can plan for the future while addressing today’s challenges. Visit us at #ESTRO24 to learn more. 

Are you a leader at a patient organization? If so, you won’t want to miss the third installment of our five-part Patient Organization Webinar Series. Join fellow leaders for Changing Oncology Landscape: Considerations for Oncology Organizations and Registries. 📅 Wednesday, June 26, 2024, 11:00 AM EDT 📌 Webinar 🎙️ Audra Moran, Kapila Viges, Jeff Hodge, Murray Aitken 🔗 Register here: https://lnkd.in/ehRnEdkj #PatientAdvocacy #PatientOutcomes

The oncology care field is reaching another critical turning point, driven by rapidly advancing technologies, policy shifts, and aging populations. In this latest Q-Centrix blog post, our Vice President, Oncology Market Lead, Karen Schmidt, draws on her extensive market knowledge to examine several urgent, strategic decisions facing oncology leaders today: https://bit.ly/4bMcEel #OncologyData #CancerRegistry #ClinicalDataManagement

Feeling tired after a busy day yesterday at the ASCO Annual Meeting? Don't worry, we've got you covered! Swing by booth 12045 for a much-needed coffee boost and discover how our solutions are revolutionizing precision oncology for research and clinical teams. From accelerating clinical trials to improving patient outcomes, we're here to support you! #ASCO24 #PrecisionOncology #ClinicalTrials #PatientOutcomes

Genelux recently received FDA Fast Track Designation for our ongoing Phase 3 trial. This designation reflects the FDA’s recognition of a product’s potential to address serious unmet medical needs. The development and review of Olvi-Vec will have benefits such as potential increased communication opportunities, rolling review, priority review, and possible accelerated approval as the trial progresses. Sponsors with Fast Track Designation receive timely feedback and can submit portions of the application for review as they become available. While the designation streamlines the approval process, the fundamental requirements for conducting rigorous clinical trials remain unchanged. Overall, fast track designation is intended to enable Genelux to efficiently develop our promising treatment and ensure quicker access for patients facing urgent medical conditions. #GNLX #Stage4needsmore #cancerresearch #drugdevelopment #cancer #nasdaq

The oncology care field is reaching another critical turning point, driven by rapidly advancing technologies, policy shifts, and aging populations. In this latest Q-Centrix blog post, our Vice President, Oncology Market Lead, Karen Schmidt, draws on her extensive market knowledge to examine several urgent, strategic decisions facing oncology leaders today: https://bit.ly/4bMcEel #OncologyData #CancerRegistry #ClinicalDataManagement

Join me in congratulating APOLLO PROTON on the successful completion of their recent webinar on Quality and Safety in Oncology Care. The webinar provided useful insights into the integration of digital innovations in modern oncology healthcare, as well as key metrics to monitor in oncology hospitals. This is a great opportunity for healthcare professionals to learn and stay up-to-date in their field. # Apollo #APOLLO PROTON! #QualityCare #OncologyHealthcare #DigitalInnovations #APOLLOPROTON #healthcareprofessionals.

#WorldCancerDay 🌍 Our Chief Medical Officer, Sonia Quaratino, speaks on World Cancer Day. In this captivating episode, she shares enlightening perspectives on cancer treatments and how Innate Pharma continues to innovate to bring solutions to patients 💪 #InnatePharma #CancerResearch #MedicalInnovation

Come learn about how our data marketplace is powering more precise and effective pharma marketing!

In oncology, we have come to expect rapid, innovative clinical development that provides life-changing care for patients. The evolving science puts pressure on the healthcare system and oncologists. This Tuesday, Sept. 10, my ZS colleagues, Christina Corridon and Matt Furlow, will be hosting a webinar about the role that pharma can play in bridging the gap between scientific progress and patient well-being. Register here: https://lnkd.in/gxPs27ab #oncology #zs #patientoutcomes